Aurinia Pharmaceuticals Inc. (AUPH) Revenue 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$283.1MFY2025 · since FY2018: $463,000 → $283.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $283.1M | +20.4% |
| FY2024 | $235.1M | +34.0% |
| FY2023 | $175.5M | +31.0% |
| FY2022 | $134.0M | +193.9% |
| FY2021 | $45.6M | -9.0% |
| FY2020 | $50.1M | +15660.4% |
| FY2019 | $318,000 | -31.3% |
| FY2018 | $463,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH Net incomeAUPH Net marginAUPH Gross profitAUPH Gross marginAUPH Operating incomeAUPH Operating marginAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →